Clonogenic Growth in Advanced Breast Cancer
Author Information
Author(s): V. Hug, A. Polyzos, S. Tucker, H. Thames
Primary Institution: The University of Texas M.D. Anderson Cancer Center
Hypothesis
Does the clonogenic growth of metastatic breast tumors correlate with patient survival?
Conclusion
Clonogenic growth of breast tumor samples does not significantly reflect the tumor features that determine the course of advanced disease.
Supporting Evidence
- Clonogenic growth correlated weakly with patient survival.
- Performance status and tumor bulk were stronger predictors of survival.
- Clonogenicity was only significant under hormone-supplemented conditions.
Takeaway
The study looked at how well breast cancer cells grow in the lab and found it doesn't really help predict how long patients will live.
Methodology
The study measured clonogenic growth of breast cancer samples from patients and analyzed the correlation with patient survival over a median follow-up of 6 years.
Limitations
The study found weak correlations and noted that clonogenicity was only significant under hormone-supplemented conditions.
Participant Demographics
107 patients with advanced breast carcinoma, including 25 with locoregional disease and 85 with distant metastatic disease.
Statistical Information
P-Value
p<0.00001
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website